Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 6 pages · Chinese
Wuhan Healthgen Biotechnology Corp on 6ix
Earlier from Wuhan Healthgen Biotechnology
- Announcement on Circulation of Restricted Stocks in Offline Placement of Initial Public Offering
- Announcement on Preliminary Earnings Estimate for 2025
- Earnings Preannouncement for 2025
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on Replacing with Raised Funds Self-raised Funds Invested in Advance in Investment Projects Financed by Raised Funds and Used to Pay Issuance Fee
Later from Wuhan Healthgen Biotechnology
- On-site Inspection Report on Continuous Supervision of WUHAN HEALTHGEN BIOTECHNOLOGY CORP. by GUOTAI HAITONG SECURITIES CO., LTD. in 2025
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Semi-annual Tracking Report on Continuous Supervision of WUHAN HEALTHGEN BIOTECHNOLOGY CORP. in 2025
- Announcement on Pledge of Partial Shares by Shareholders with Over 5% of Shares
- Announcement on Resolutions of the 2025 Annual General Meeting
Follow Wuhan Healthgen Biotechnology into a list and get an email when it puts out news.
Follow Wuhan Healthgen Biotechnology